EX-2.1
from 8-K
36 pages
Certain Information Contained in This Exhibit, Marked by [***], Has Been Excluded From This Exhibit Because the Registrant Has Determined That It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Asset Purchase Agreement by and Among Zentalis Pharmaceuticals, Inc., Zeno Management, Inc. and Immunome, Inc. Dated as of October 25, 2024
12/34/56
EX-2.1
from 425
108 pages
Agreement and Plan of Merger and Reorganization by and Among: Immunome, Inc., a Delaware Corporation; Ibiza Merger Sub, Inc., a Delaware Corporation; and Morphimmune Inc., a Delaware Corporation Dated as of June 29, 2023
12/34/56
EX-2.1
from 8-K
108 pages
Agreement and Plan of Merger and Reorganization by and Among: Immunome, Inc., a Delaware Corporation; Ibiza Merger Sub, Inc., a Delaware Corporation; and Morphimmune Inc., a Delaware Corporation Dated as of June 29, 2023
12/34/56
